Evidence map›Paper›PMID 31243236›Full record

ArticleInternal medicine (Tokyo, Japan)2019

Fabry Disease with Pacemaker Implantation as the Initial Event.

Yuji Kato, Ayako Ishikawa, Satoshi Aoki, Hiroyuki Sato, Yoshie Ojima, Saeko Kagaya, Tasuku Nagasawa

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Yuji KatoDepartment of Nephrology, Japanese Red Cross Ishinomaki Hospital, Japan.
Ayako IshikawaDepartment of Internal Medicine, Tohoku Kosai Hospital, Japan.
Satoshi AokiDepartment of Nephrology, Japanese Red Cross Ishinomaki Hospital, Japan.
Hiroyuki SatoDepartment of Nephrology, Japanese Red Cross Ishinomaki Hospital, Japan.
Yoshie OjimaDepartment of Nephrology, Japanese Red Cross Ishinomaki Hospital, Japan.
Saeko KagayaDepartment of Nephrology, Hypertension and Endocrinology, Tohoku University School of Medicine, Japan.
Tasuku NagasawaDepartment of Nephrology, Hypertension and Endocrinology, Tohoku University School of Medicine, Japan.
Tohoku University · JPKKR Tohoku Kosai Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fabry disease (FD) is a rare X-linked hereditary disorder (Xq22) caused by a deficiency in alpha-galactosidase activity. A 34-year-old man was referred to our hospital because of renal dysfunction. He had previously undergone pacemaker implantation at 24 years of age. Investigations revealed undetectable alpha-galactosidase A activity levels. Renal biopsy results indicated vacuolization of podocytes. A genetic analysis revealed that the patient carried the W340X mutation. Enzyme replacement therapy with agalsidase beta was started. This case is novel because most cases of FD nephropathy precede cardiac disease. In our patient, the cardiac event was the initial event, and renal impairment followed.

Indexed as

Pacemaker, ArtificialAdultArrhythmias, CardiacBiopsyElectrocardiographyFabry DiseaseHumansKidneyMaleRenal Insufficiency, Chronicchronic kidney diseaseFabry diseaseLyso-Gb3mulberry cellpacemaker implantationW340X

Identifiers

PMID31243236
PMCPMC6859394
OpenAlexW2954826316

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.